• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death.在具有药理相关性的浓度下,静脉铁制剂会引起胰腺β细胞死亡。
Am J Transl Res. 2013 Dec 1;6(1):64-70. eCollection 2013.
2
Toxic effects of IV iron preparations in CKD patients.静脉注射铁剂对慢性肾脏病患者的毒性作用。
Nephrol News Issues. 2014 Feb;28(2):4-5.
3
Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.铁蔗糖促进内皮损伤和功能障碍以及单核细胞黏附和浸润。
Am J Nephrol. 2012;35(2):114-9. doi: 10.1159/000334939. Epub 2011 Dec 29.
4
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.铁蔗糖可损害多形核白细胞的吞噬功能并促进其凋亡。
Am J Nephrol. 2012;36(1):50-7. doi: 10.1159/000339285. Epub 2012 Jun 19.
5
The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress.铁代谢、活性氧和活性氮之间的复杂相互作用:深入了解各种铁疗法诱导氧化应激和亚硝化应激的潜力。
Free Radic Biol Med. 2013 Dec;65:1174-1194. doi: 10.1016/j.freeradbiomed.2013.09.001. Epub 2013 Sep 12.
6
Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.血液透析患者接受静脉注射右旋糖酐铁或蔗糖铁后,非转铁蛋白结合铁、细胞因子激活和细胞内活性氧生成。
Biometals. 2011 Aug;24(4):603-13. doi: 10.1007/s10534-011-9409-6. Epub 2011 Jan 13.
7
Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).一项前瞻性、开放性、探索性、随机、单中心比较研究的方案和基线数据,旨在确定各种静脉铁制剂对慢性肾脏病(IRON-CKD)患者氧化应激和肾损伤标志物的影响。
Trials. 2019 Apr 4;20(1):194. doi: 10.1186/s13063-019-3291-x.
8
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.血液透析中静脉铁剂的安全性:蔗糖铁与葡萄糖酸铁钠复合物的长期比较
Am J Kidney Dis. 2017 Jun;69(6):771-779. doi: 10.1053/j.ajkd.2016.10.031. Epub 2017 Jan 4.
9
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.血液透析患者静脉注射右旋糖酐铁、葡萄糖酸铁钠和蔗糖铁后氧化应激标志物的比较。
Pharmacotherapy. 2007 Mar;27(3):343-50. doi: 10.1592/phco.27.3.343.
10
Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.静脉注射维生素 C 对接受静脉注射蔗糖铁的终末期肾病患者细胞因子激活和氧化应激的影响。
Biometals. 2012 Oct;25(5):961-9. doi: 10.1007/s10534-012-9562-6. Epub 2012 Jun 17.

引用本文的文献

1
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus.靶向铁死亡:间充质干细胞治疗1型糖尿病的机遇与挑战
Stem Cell Res Ther. 2025 Feb 4;16(1):47. doi: 10.1186/s13287-025-04188-7.
2
RISING STARS: Evidence for established and emerging forms of β-cell death.新星崛起:β细胞死亡的既定形式和新兴形式的证据。
J Endocrinol. 2024 Jul 4;262(2). doi: 10.1530/JOE-23-0378. Print 2024 Aug 1.
3
Phenolic Acids Rescue Iron-Induced Damage in Murine Pancreatic Cells and Tissues.酚酸可挽救铁诱导的小鼠胰腺细胞和组织损伤。
Molecules. 2023 May 14;28(10):4084. doi: 10.3390/molecules28104084.
4
Ferroptosis Signaling in Pancreatic β-Cells: Novel Insights & Therapeutic Targeting.铁死亡信号在胰腺β细胞中的作用:新的见解和治疗靶点。
Int J Mol Sci. 2022 Nov 8;23(22):13679. doi: 10.3390/ijms232213679.
5
Regulatory Connections between Iron and Glucose Metabolism.铁与糖代谢的调控关系
Int J Mol Sci. 2020 Oct 21;21(20):7773. doi: 10.3390/ijms21207773.
6
HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation.HPO 铁螯合剂 CP655 通过上调 p21 导致 G1/S 期细胞周期阻滞。
Immun Inflamm Dis. 2020 Dec;8(4):568-583. doi: 10.1002/iid3.342. Epub 2020 Aug 31.
7
Acute Effects of Blood Transfusion on Insulin Sensitivity and Pancreatic β-Cell Function in Children with β-Thalassemia/Hemoglobin E Disease.输血对β-地中海贫血/血红蛋白E病患儿胰岛素敏感性和胰腺β细胞功能的急性影响
J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):1-7. doi: 10.4274/jcrpe.4774. Epub 2017 Jul 24.
8
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century.21世纪初透析患者的医源性铁过载
Drugs. 2016 May;76(7):741-57. doi: 10.1007/s40265-016-0569-0.
9
Safety concerns about intravenous iron therapy in patients with chronic kidney disease.慢性肾脏病患者静脉铁剂治疗的安全性问题。
Clin Kidney J. 2016 Apr;9(2):260-7. doi: 10.1093/ckj/sfv142. Epub 2016 Jan 6.
10
Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study.贫血严重程度可预测慢性肾脏病患者的住院时间,但不能预测再入院情况:一项回顾性队列研究
Medicine (Baltimore). 2015 Jun;94(25):e964. doi: 10.1097/MD.0000000000000964.

本文引用的文献

1
Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis.了解铁:促进接受血液透析治疗的慢性肾衰竭患者安全使用铁剂。
Am J Kidney Dis. 2013 Jun;61(6):992-1000. doi: 10.1053/j.ajkd.2012.10.027. Epub 2013 Jan 31.
2
Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.促红细胞生成素治疗时代与血液透析相关的血色素沉着症:一项 MRI 研究。
Am J Med. 2012 Oct;125(10):991-999.e1. doi: 10.1016/j.amjmed.2012.01.015.
3
Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.静脉铁剂导致透析人群铁过载流行:呼吁适度使用
Am J Med. 2012 Oct;125(10):951-2. doi: 10.1016/j.amjmed.2012.02.009. Epub 2012 Jul 13.
4
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.铁蔗糖可损害多形核白细胞的吞噬功能并促进其凋亡。
Am J Nephrol. 2012;36(1):50-7. doi: 10.1159/000339285. Epub 2012 Jun 19.
5
Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.铁蔗糖促进内皮损伤和功能障碍以及单核细胞黏附和浸润。
Am J Nephrol. 2012;35(2):114-9. doi: 10.1159/000334939. Epub 2011 Dec 29.
6
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease.血清铁标志物不能充分指导慢性肾脏病的铁补充。
Clin J Am Soc Nephrol. 2011 Jan;6(1):77-83. doi: 10.2215/CJN.04190510. Epub 2010 Sep 28.
7
Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival.不同静脉铁制剂对淋巴细胞内活性氧生成和亚群存活的影响。
BMC Nephrol. 2010 Aug 17;11:16. doi: 10.1186/1471-2369-11-16.
8
Histologic studies of islets of Langerhans in transplanted pancreata from marginal donors in Japan.日本边缘供体移植胰腺中朗格汉斯胰岛的组织学研究。
Transplant Proc. 2010 Jun;42(5):1819-21. doi: 10.1016/j.transproceed.2010.02.080.
9
Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.静脉注射蔗糖铁对血液透析中急性影响的随机临床试验。
Nephrology (Carlton). 2010 Mar;15(2):178-83. doi: 10.1111/j.1440-1797.2009.01174.x.
10
Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence.
Biol Pharm Bull. 2008 Jun;31(6):1265-9. doi: 10.1248/bpb.31.1265.

在具有药理相关性的浓度下,静脉铁制剂会引起胰腺β细胞死亡。

At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death.

机构信息

Departments of Surgery and Medicine, University of California Irvine, CA, USA.

出版信息

Am J Transl Res. 2013 Dec 1;6(1):64-70. eCollection 2013.

PMID:24349622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3853425/
Abstract

BACK GROUND

Overt and subtle iron overload cause diabetes by lowering insulin production and promoting insulin resistance. Via divalent metal transporters pancreatic beta cells take up non-transferrin-bound iron which by catalyzing Fenton reaction can cause oxidative stress. Due to their strict dependence on mitochondrial glucose metabolism and limited antioxidant capacity, beta cells are exquisitely vulnerable to oxidative stress and hence catalytically active iron. Intravenous (IV) iron preparations are routinely used in the management of anemia in patients with end stage renal disease. This has led to an epidemic of iron overload in this population. This study explored the effect of pharmacologically-relevant concentrations of a commonly used IV iron preparation on the beta cells in isolated pancreatic islets.

METHODS

Isolated rat pancreatic islets were incubated for 24 hours in culture media containing vehicle or pharmacologically-relevant concentration of ferric sucrose and examined for the extent of cell death and oxidative stress.

RESULTS

Exposure to iron sucrose resulted in a concentration-dependent oxidative stress and pancreatic islet cell death predominantly affecting beta cells.

CONCLUSIONS

At pharmacologically-relevant concentrations a commonly used IV iron preparation causes oxidative stress and beta cell death. These findings suggest that indiscriminate use of IV iron may impair insulin production capacity in ESRD patients the majority of whom have Type-2 diabetes.

摘要

背景

显性和隐性铁过载通过降低胰岛素分泌和促进胰岛素抵抗导致糖尿病。通过二价金属转运蛋白,胰岛β细胞摄取非转铁蛋白结合铁,铁通过芬顿反应可以引起氧化应激。由于β细胞严格依赖于线粒体葡萄糖代谢和有限的抗氧化能力,因此对氧化应激和催化活性铁非常敏感。静脉内(IV)铁制剂常规用于治疗终末期肾病患者的贫血。这导致该人群中铁过载的流行。本研究探讨了常用 IV 铁制剂的药理相关浓度对分离胰岛中β细胞的影响。

方法

将分离的大鼠胰岛在含有载体或药理相关浓度的蔗糖铁的培养基中孵育 24 小时,并检查细胞死亡和氧化应激的程度。

结果

暴露于蔗糖铁导致浓度依赖性氧化应激和胰岛细胞死亡,主要影响β细胞。

结论

在药理相关浓度下,常用的 IV 铁制剂会引起氧化应激和β细胞死亡。这些发现表明,在 ESRD 患者中,大量患有 2 型糖尿病的患者中,IV 铁的滥用可能会损害胰岛素的产生能力。